Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest announcement is out from Themis Medicare Limited ( (IN:THEMISMED) ).
Themis Medicare Limited has announced the closure of its trading window for dealings in the company’s shares from 1 April 2026, in line with SEBI’s Prohibition of Insider Trading Regulations and its own code of conduct. The window will remain shut until 48 hours after the board approves and discloses the audited financial results for the quarter ending 31 March 2026, temporarily restricting insider trading by designated persons and reinforcing regulatory compliance for investors.
The board meeting date to consider these audited quarterly results will be communicated separately to the exchanges, signaling that earnings disclosure is upcoming but not yet scheduled. This procedural move, standard among listed companies, underscores Themis Medicare’s adherence to market transparency norms and provides stakeholders with clarity on trading restrictions around the results period.
More about Themis Medicare Limited
Themis Medicare Limited operates in the pharmaceutical and healthcare sector, with a focus on manufacturing and marketing formulations and active pharmaceutical ingredients for domestic and international markets. The company’s shares are listed on Indian stock exchanges, where it is subject to SEBI regulations on disclosure and insider trading compliance.
Average Trading Volume: 5,857
Technical Sentiment Signal: Sell
Current Market Cap: 6.56B INR
For detailed information about THEMISMED stock, go to TipRanks’ Stock Analysis page.